EPM speaks to a number of key players in contract manufacturing to get their thoughts on the sector’s changing landscape.
Roundtable
Featuring:
Mark Quick, executive vice president – corporate development, Recipharm
Bobby Sheng, CEO, Bora Pharmaceuticals
Manuel Leal, director of business development, Idifarma
Vincent Dunne, CEO, The Wasdell Group
Tom Wilson, VP, global contract manufacturing leader, Pfizer CentreOne
Andrew Henderson, sales and marketing director, Sterling Pharma Solutions
The CMO market has been predicted a CAGR of over 7.75% between 2019 and 2024, what do you attribute the anticipated trajectory to? Why are companies outsourcing more of their manufacturing requirements?